Pharmacokinetics, Biodistribution, Radiation Dose and Safety Study of 68Ga-NYM032 in Patients

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

June 4, 2024

Primary Completion Date

October 28, 2024

Study Completion Date

October 28, 2024

Conditions
Prostate Cancer
Interventions
DRUG

68Ga-NYM032 injection

The radiation dose is about 3-6 mCi for a single patient.Using a syringe to withdraw 68Ga-NYM032 injection, the dose will be administered via an intravenous injection and the injection time will be about 45-60 seconds.

Trial Locations (2)

214000

Affliated Hospital of Jiangnan University, Wuxi

Unknown

Peking Union Medical College Hospital, Beijing

All Listed Sponsors
lead

Norroy Bioscience Co., LTD

INDUSTRY

NCT06389695 - Pharmacokinetics, Biodistribution, Radiation Dose and Safety Study of 68Ga-NYM032 in Patients | Biotech Hunter | Biotech Hunter